Cerebral perfusion of metabolic inactivators: A new method for rapid fixation of labile lipid pools in brain

This paper describes a new method for the rapid fixation of labile lipid pools in the brain. Perfusion of the brain with 0.9% saline containing esterase inhibitors (p-bromphenacyl-bromide and diisopropyl fluorophosphate), an antioxidant (nordihydroguaiaretic acid) and a Ca²⁺ chelator (EDTA) resulted in a substantial reduction in the levels of free fatty acids, a biochemical marker for the degradation of labile membrane lipids. Levels of unesterified polyunsaturated fatty acids in whole brain were decreased by 90–96% as compared to levels in brains perfused with saline alone. Levels of docosahexaenoic acid approximated levels obtained after microwave irradiation. Unlike microwave irradiation, this perfusion technique perserves the cellular structure of the brain, thereby allowing subcellular fractionation with minimal postmortem changes in lipid pools. The release of arachidonic acid during isolation of the P₂ (synaptosomal) fraction was completely inhibited by the presence of the metabolic inactivators. The results of this study demonstrate a new and useful technique for the postmortem inactivation of enzymes responsible for the degradation of labile lipids in the brain. Further, the data underscore the key role of phospholipase A₂ and Ca²⁺ in mediating the release and accumulation of free fatty acids in the ischemic brain.Abbreviations 204 arachidonic acid - 226 docosahexaenoic acid - 160 palmitic acid - 180 stearic acid - 181 oleic acid - 182 linoleic acid - NDGA nordihydroguaiaretic acid - pBPB p-bromphenacylbromide - EDTA ethylenediamine-tetraacetic acid - DFP diisopropyl fluorophosphate - FFA free fatty acids - TLC thin layer chromatography - GLC gas liquid chromatography